Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-sedating antihistamines.

M A Kaliner1, W A Check

  • 1Allergic Diseases Section, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research abstracts presented at the 46th annual scientific session of the Western Society of Allergy, Asthma, and Immunology.

Allergy and asthma proceedings·2017
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

The Journal of allergy and clinical immunology·2012
Same author

Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper.

International archives of allergy and immunology·2012
Same author

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

Allergy·2010
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Allergy·2008
Same author

Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings.

Allergy·2007
Same journal

William III (1650-1702) Prince of Orange and King of England, Scotland, and Ireland.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Sir John Floyer (1649-1734) British physician and pioneer clinical investigator.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Nicolas Boileaux-Despreaux (1636-1711) French poet, author, and literary critic.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

John Locke (1632-1704) British physician and philosopher.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Chu I-Hai, Prince of Lu (1618-1662) last regent of the Chinese Ming dynasty.

Allergy proceedings : the official journal of regional and state allergy societies·1995
Same journal

Atopy and skin reactivity at school age in children followed up from birth, with special reference to atopy prevention in infancy and atopic findings at preschool age.

Allergy proceedings : the official journal of regional and state allergy societies·1995
See all related articles

New non-sedating antihistamines offer effective relief for allergy symptoms and chronic urticaria. These modern medications provide therapeutic benefits without the drowsiness or anticholinergic side effects common with older antihistamines.

Area of Science:

  • Pharmacology
  • Allergy and Immunology

Background:

  • Antihistamines are crucial for managing histamine-mediated conditions like allergic rhinitis and chronic urticaria.
  • Traditional antihistamines often cause drowsiness and anticholinergic side effects.
  • The development of non-sedating antihistamines represents a significant advancement in allergy treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety profile of newly developed non-sedating antihistamines.
  • To compare the side effect profile of non-sedating antihistamines with traditional agents and placebo.
  • To explore the pharmacological characteristics contributing to the non-sedating properties of these agents.

Main Methods:

  • Clinical trials were conducted to assess the therapeutic effectiveness of new antihistamines.

Related Experiment Videos

  • Pharmacokinetic studies, including half-life determination, were performed for specific agents like astemizole.
  • Comparative analysis of central nervous system and anticholinergic side effects against placebo and older antihistamines.

    • Main Results:

    • Non-sedating antihistamines, including terfenadine and astemizole, demonstrate efficacy comparable to classical antihistamines.
    • These newer agents exhibit minimal to no central nervous system or anticholinergic side effects.
    • Evidence suggests reduced blood-brain barrier penetration and minimal cholinergic receptor binding contribute to their safety profile.
    • Astemizole metabolites show a long elimination half-life (12-18 days).

    Conclusions:

    • Non-sedating antihistamines provide an effective and safer alternative for treating histamine-mediated conditions.
    • The improved safety profile is attributed to their specific pharmacological properties, including limited CNS penetration.
    • These advancements offer improved patient compliance and quality of life in managing allergic diseases.